These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18092653)

  • 1. Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.
    Ikenaga N; Otomo N; Toyofuku A; Ueda Y; Toyoda K; Hayashi T; Nishikawa K; Tanaka M
    Am Surg; 2007 Nov; 73(11):1151-7. PubMed ID: 18092653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
    Ueda S; Tsuda H; Asakawa H; Shigekawa T; Fukatsu K; Kondo N; Yamamoto M; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H
    Jpn J Clin Oncol; 2008 Apr; 38(4):250-8. PubMed ID: 18407934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of pretreatment SUV in 18F-FDG/PET in breast cancer: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
    Baba S; Isoda T; Maruoka Y; Kitamura Y; Sasaki M; Yoshida T; Honda H
    J Nucl Med; 2014 May; 55(5):736-42. PubMed ID: 24665089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma.
    Ekmekcioglu O; Aliyev A; Yilmaz S; Arslan E; Kaya R; Kocael P; Erkan ME; Halac M; Sonmezoglu K
    Nucl Med Commun; 2013 Nov; 34(11):1055-67. PubMed ID: 24025919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
    Heudel P; Cimarelli S; Montella A; Bouteille C; Mognetti T
    Int J Clin Oncol; 2010 Dec; 15(6):588-93. PubMed ID: 20809217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
    Wang CL; MacDonald LR; Rogers JV; Aravkin A; Haseley DR; Beatty JD
    AJR Am J Roentgenol; 2011 Aug; 197(2):W247-55. PubMed ID: 21785049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.
    Kim BS; Sung SH
    Ann Nucl Med; 2012 Feb; 26(2):175-83. PubMed ID: 22139552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour and lymph node uptakes on dual-phased 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography correlate with prognostic parameters in breast cancer.
    Chang CC; Tu HP; Chen YW; Lin CY; Hou MF
    J Int Med Res; 2014 Dec; 42(6):1209-21. PubMed ID: 25339454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
    Specht JM; Tam SL; Kurland BF; Gralow JR; Livingston RB; Linden HM; Ellis GK; Schubert EK; Dunnwald LK; Mankoff DA
    Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative FDG-PET for axillary metastases in patients with breast cancer.
    Chung A; Liou D; Karlan S; Waxman A; Fujimoto K; Hagiike M; Phillips EH
    Arch Surg; 2006 Aug; 141(8):783-8; discussion 788-9. PubMed ID: 16924086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.
    Crippa F; Seregni E; Agresti R; Chiesa C; Pascali C; Bogni A; Decise D; De Sanctis V; Greco M; Daidone MG; Bombardieri E
    Eur J Nucl Med; 1998 Oct; 25(10):1429-34. PubMed ID: 9818284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
    Gil-Rendo A; Martínez-Regueira F; Zornoza G; García-Velloso MJ; Beorlegui C; Rodriguez-Spiteri N
    Br J Surg; 2009 Feb; 96(2):166-70. PubMed ID: 19160365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.
    Lee SW; Nam SY; Im KC; Kim JS; Choi EK; Ahn SD; Park SH; Kim SY; Lee BJ; Kim JH
    Radiother Oncol; 2008 May; 87(2):211-6. PubMed ID: 18237806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of standardized uptake value in breast cancer measured using 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Kim YH; Lee JA; Baek JM; Sung GY; Lee DS; Won JM
    Nucl Med Commun; 2015 Aug; 36(8):790-4. PubMed ID: 25932535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
    Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
    Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Standard uptake value of 18F-fluorine-2-deoxyglucose is correlated with the expression of estrogen receptor in duct carcinoma of breast].
    Wen GH; Feng YL; Deng HF; Yu FZ; Liu DJ; Yuan JW; He XH; Huang KM; Liu SS; Yang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):448-50. PubMed ID: 18575338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.